From the endometrium physiology to a comprehensive strategy for the discovery of ovarian cancer biomarkers
The development of comprehensive strategies for biomarker discovery of gynecological cancers is needed. The unique physiology of the female genital track revolves around ovulatory cycles ending by the proteolysis of the endometrium triggered by progesterone decline during the last part of the luteal...
Main Authors: | Janos L. Tanyi, Nathalie Scholler |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-12-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://www.oncologyreviews.org/index.php/or/article/view/47 |
Similar Items
-
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
by: Jorge A. Alegría-Baños, et al.
Published: (2021-07-01) -
The role of asymptomatic screening in the detection of recurrent ovarian cancer
by: M.T. Richardson, et al.
Published: (2020-08-01) -
Automated Assay of a Four-protein Biomarker Panel for Improved Detection of Ovarian Cancer
by: Christopher Walker, et al.
Published: (2021-01-01) -
Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
by: Noor A. Lokman, et al.
Published: (2021-01-01) -
Galectin-1 as a predictive biomarker in ovarian cancer
by: Mahak Masoodi, et al.
Published: (2021-09-01)